MARKETS

BSE Prices delayed by 5 minutes... Prices as on Oct 17, 2018   ABB India 1284 [ -1.23% ]ACC 1539.9 [ -0.73% ]Ambuja Cements Ltd. 218.1 [ -1.49% ]Asian Paints Ltd. 1256.2 [ -0.84% ]Axis Bank Ltd. 574.6 [ -2.41% ]Bajaj Auto Ltd. 2548.05 [ -2.42% ]Bank of Baroda 99.25 [ -0.75% ]Bharti Airtel 288.1 [ -1.97% ]Bharat Heavy Ele 73.9 [ -3.02% ]Bharat Petroleum 285.1 [ -5.72% ]Britannia Ind. 5530 [ -2.94% ]Cairn India Ltd. 285.4 [ 0.90% ]Cipla 640.15 [ 0.02% ]Coal India 279.65 [ 1.14% ]Colgate Palm. 1082.85 [ -1.42% ]Dabur India 401.75 [ -1.08% ]DLF Ltd. 144.45 [ -8.69% ]Dr. Reddy's Labs 2562.35 [ -0.43% ]GAIL (India) Ltd. 345.55 [ -1.85% ]Grasim Inds. 884.05 [ -2.62% ]HCL Technologies 1023.85 [ 2.08% ]HDFC 1736.3 [ -1.17% ]HDFC Bank 1974.95 [ -0.88% ]Hero MotoCorp 2815.1 [ -2.88% ]Hindustan Unilever L 1561.05 [ 1.08% ]Hindalco Indus. 227.55 [ -1.32% ]ICICI Bank 314.7 [ -1.98% ]IDFC L 37.65 [ -4.56% ]Indian Hotels Co 125.55 [ 0.92% ]IndusInd Bank 1603.8 [ -1.05% ]Infosys 704.5 [ 1.16% ]ITC Ltd. 286.35 [ 1.34% ]Jindal St & Pwr 168.5 [ -5.73% ]Kotak Mahindra Bank 1178.05 [ 0.11% ]L&T 1211.25 [ -1.07% ]Lupin Ltd. 895.4 [ 0.00% ]Mahi. & Mahi 760.05 [ -2.34% ]Maruti Suzuki India 6878.7 [ -3.79% ]MTNL 13.73 [ -1.93% ]Nestle India 9720.8 [ -0.14% ]NIIT Ltd. 73 [ -3.57% ]NMDC Ltd. 110.7 [ -2.38% ]NTPC 162.75 [ -0.76% ]ONGC 162.1 [ -2.05% ]Punj. NationlBak 66.45 [ -4.80% ]Power Grid Corpo 189.1 [ 0.56% ]Reliance Inds. 1148.9 [ -1.27% ]SBI 261.15 [ -3.35% ]Vedanta 208 [ -2.05% ]Shipping Corpn. 42.6 [ -4.16% ]Sun Pharma. 593.45 [ -1.56% ]Tata Chemicals 670.6 [ -0.67% ]Tata Global Beverage 231.1 [ -1.45% ]Tata Motors Ltd. 179.2 [ -3.40% ]Tata Steel 554.65 [ -3.39% ]Tata Power Co. 72.4 [ -1.90% ]Tata Consultancy 1927.7 [ -1.73% ]Tech Mahindra Ltd. 718.9 [ 0.07% ]UltraTech Cement 3730.4 [ -0.64% ]United Spirits 533.2 [ 1.29% ]Wipro Ltd 324 [ 1.20% ]Zee Entertainment En 463.5 [ -1.46% ]

News Details

You can view in detail.
Cipla bags approval for Isoproterenol Hydrochloride Injection 14/06/2018 09:26

Cipla Limited (“Cipla”), has said that it has received final approval for its Abbreviated New Drug Application (ANDA) for Isoproterenol Hydrochloride Injection USP, 0.2mg/mL, single - use sterile Ampoule from the United States Food and Drug Administration (US FDA ).

Cipla’s Isoproterenol Hydrochloride Injection USP, 0.2mg/mL, ampoule is AP - rated generic therapeutic equivalent version of Hospira Inc’s Isuprel ® Injection, 0.2mg/m.

According to IQVIA (IMS Health), Isuprel Injection and its generic equivalents had US sales of approximately USD 1 48 M for the 12-month period ending April 2018.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Meanwhile, shares of the company were trading at Rs 589.30 apiece up 1.36 per cent from the previous close at 09:28 hrs on BSE.

LOAD MORE